Literature DB >> 739556

Acetylcholinesterase activity in ventricular and cisternal CSF of dogs: effect of chlorpromazine.

S R Bareggi, E Giacobini.   

Abstract

Acetylcholinesterase (AChE) activity in dog plasma is significantly higher than in either ventricular or cisternal CSF. However, since protein levels in plasma are about 100-fold higher than in CSF, the specific activity of AChE is lower in plasma than in CSF. Acetylcholinesterase activity in plasma represents only 22% of total cholinesterase (ChE) activity, while preliminary findings indicate that in ventricular CSF it is 50-60%. Acetylcholinesterase activity in ventricular CSF is significantly lower than in cisternal CSF. Chlorpromazine (10 mg/kg, intravenous), a drug which increases acetylcholine turnover, increased AChE-specific activity in all dogs. Our results support the hypothesis of a neuronal origin of AChE activity in CSF.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 739556     DOI: 10.1002/jnr.490030504

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Presence of a soluble form of acetylcholinesterase in human ocular fluids.

Authors:  M E Appleyard; B McDonald; L Benjamin
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

2.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

3.  Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.

Authors:  J Sirviö; R Kutvonen; H Soininen; P Hartikainen; P J Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Increased acetylcholinesterase activity in selected regions of rat brain after chronic (-)-deprenyl administration.

Authors:  M K Lakshmana; S Jagadeesh; M N Subhash
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

Review 5.  Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

Authors:  E Giacobini
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.